One sample. All the answers.

Comprehensive analysis of therapy-relevant genome alterations for individualized cancer therapy

NEOliquid

Non-invasive blood test for molecular cancer diagnostics

Prospective registry for molecular diagnostics in lung cancer patients

 

 

Play Video

personalized


Cancer is a disease of the genome and can be treated individually with targeted therapies. Our NEOplus test is capable of identifying the specific genome alterations responsible for each cancer type. This enables the treating physician to select the most suitable targeted therapy for the patient.

informed


We take care of the entire analytical process. Our team includes some of the most renowned German cancer researchers. With their expertise they advise doctors on individualized cancer therapies with targeted drugs.

fast


A single sample from the patient is sufficient for the analysis. We guarantee a comprehensive test report within 10-15 working days, allowing the physician to treat the patient in the most time efficient manner.


Who we are

The founding and management team of New Oncology.

Diagnostic

Comprehensive molecular genetic diagnostics with NEOplus.

FAQs

Frequently asked questions.

Current and latest news

Current press releases, talks and reports.

Kontakt

Telephone

Office: +49.221.888.23 80
Diagnostics: +49.221.888.23 836

More information

NEO test

Address

NEO New Oncology GmbH
Gottfried-Hagen-Str. 20
51105 Cologne
Germany